News & Press Releases

Easily Measure Cancer Cell Death in a Co-Culture with KILR™ Assays from DiscoverX

Announcing the launch of the KILR™ Cytotoxicity Assay

Rapidly Develop Drugs Targeting Interleukins with New PathHunter® Cell-Based Assays from DiscoverX

PathHunter® portfolio expansion with Interleukin cell-based assays

DiscoverX Enables Predictive In Vitro Drug Combination Studies with launch of BioMAP® Combo ELECT

Primary Human Cell Models Identify Potential Safe and Efficacious Drug Combinations

DiscoverX Platforms for Phenotypic and Target Based Screening Provide Unique Tools for Cancer Therapeutic Discovery

Primary Human Cell and Co-Culture Assay Systems for Oncology Highly Predictive of Drug Activity in<br /> Relation to Inflammation, Neo-Vascularization and Tumor Microenvironments<br /> <br /> Capabilities for Cancer Drug Discovery Highlighted in &lsquo;Advanced Drug Delivery Reviews&rsquo; Publication<br /> and American Association of Cancer Research 2014 Meeting Presentations<br /> &nbsp;

Displaying results 11-20 (of 46)
 |<  <  1 - 2 - 3 - 4 - 5  >  >|